Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin Hykes Insider Profile
4 Followers
Kevin Hykes, Director at Hansen Medical, holds 30.00K shares in CVRx (Ticker: CVRX), holds 701.10K shares in Hansen Medical (Ticker: HNSN). Most recently, Kevin Hykes Bought ― shares of CVRx on Aug 05, 2024 for an estimated value of 250.50K.
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-44.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
PRES & CEO, Director
Roles that Kevin Hykes holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kevin Hykes
Kevin Hykes's Trading History
Hansen Medical
Jul 29, 2016
―
Uninformative Sell
280.44K
$2.78M
CVRx
Aug 05, 2024
PRES & CEO, Director
Informative Buy
250.50K
$260.70K
List of latest transactions for each holding click on a transaction to see Kevin Hykes's performance on stock
You May Also Like
Kevin Hykes insider profile FAQ
What is the percentage of profitable transactions made by Kevin Hykes?
The percentage of profitable transactions made by Kevin Hykes is 0%.
What is the average return per transaction made by Kevin Hykes?
The average return per transaction made by Kevin Hykes is -44.10%.
What stocks does Kevin Hykes hold?
Kevin Hykes holds: HNSN, CVRX stocks.
What was Kevin Hykes’s latest transaction?
Kevin Hykes latest transaction was an Informative Buy of $250.50K.
What was Kevin Hykes's most profitable transaction?
Kevin Hykes’s most profitable transaction was an Informative Buy of CVRX stock on August 5, 2024. The return on the trade was -7.20%.
What is Kevin Hykes's role in Hansen Medical?
Kevin Hykes's role in Hansen Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.